HUALAN NPM(301093.SZ)

Last Updated 00:00:00
longbridge loading
Company Encyclopedia
View More
name
HUALAN NPM
301093.SZ
Jiangsu Hualan New Pharmaceutical Material Co.,Ltd. engages in the research and development, manufacture, and sale of packaging materials for the pharmaceuticals' industry in China and internationally. It offers covered rubber stoppers serise; halogenated butyl rubber stopper freeze-dryied series; halogenated butyl rubber stopper antibiotics series; halogenated butyl rubber plugs infusion series; combination cap series for plastic infusion vessels; polyisoprene gaskets; blood plugs; halogenated butyl rubber stopper for oral dosage forms; pre-potted protective caps; medical instruments; and pen style products. The company was founded in 1992 and is based in Jiangyin, China.
338.86 B
301093.SZMarket value -Rank by Market Cap -/-

Financial Score

20/05/2026 Update
C
Health Care SuppliesIndustry
Industry Ranking16/40
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreC
    • ROE1.90%C
    • Profit Margin7.03%B
    • Gross Margin37.22%B
  • Growth ScoreD
    • Revenue YoY-0.33%D
    • Net Profit YoY-25.96%D
    • Total Assets YoY0.93%C
    • Net Assets YoY-2.67%D
  • Cash ScoreB
    • Cash Flow Margin314.56%A
    • OCF YoY-0.33%D
  • Operating ScoreD
    • Turnover0.24D
  • Debt ScoreA
    • Gearing Ratio12.81%A

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    In the year, important shareholders increased their holdings by over 93 billion yuan, setting a new high since 2023

    36Kr·
    SH
    600959
    -1.51%
    SZ
    301093
    +3.12%
    SZ
    000995
    +0.70%
    36Kr·
    SH
    600959
    -1.51%
    SZ
    301093
    +3.12%
    SZ
    000995
    +0.70%

    HUALAN NPM newly established a smart pharmaceutical technology company, including AI business

    Zhitong·
    SZ
    301093
    +3.12%
    Zhitong·
    SZ
    301093
    +3.12%

    HUALAN NPM released its performance for the first three quarters, with a net profit attributable to the parent company of 53.316 million yuan, an increase of 2.06%

    Zhitong·
    SZ
    301093
    +3.12%
    Zhitong·
    SZ
    301093
    +3.12%

    HUALAN NPM: Net profit in the third quarter was 9.5839 million yuan, a year-on-year decrease of 37.20%

    Zhitong·
    SZ
    301093
    +3.12%
    Zhitong·
    SZ
    301093
    +3.12%

    HUALAN NPM plans to establish a subsidiary in Hainan with an investment of 50 million yuan, focusing on research and development solutions and services for innovative drugs in artificial intelligence

    Zhitong·
    SZ
    301093
    +3.12%
    Zhitong·
    SZ
    301093
    +3.12%
    © 2026 Longbridge｜Disclaimer